@Article{096504016X14537290676919,
AUTHOR = {Shuang Wang, Daqi Zhao, Ruihua Tian, Hailong Shi, Xiangming Chen, Wenzhi Liu, Lin Wei},
TITLE = {FGF19 Contributes to Tumor Progression in Gastric Cancer by Promoting Migration and Invasion},
JOURNAL = {Oncology Research},
VOLUME = {23},
YEAR = {2015},
NUMBER = {4},
PAGES = {197--203},
URL = {http://www.techscience.com/or/v23n4/57556},
ISSN = {1555-3906},
ABSTRACT = {Gastric cancer is the fourth most common type of cancer and second leading cause of cancer-related death in 
the world. Since patients are often diagnosed at a late stage, very few effective therapies are left in the arsenal. 
FGF19, as a hormone, has been reported to promote tumor growth in various types of cancer; however, its 
function in gastric cancer remains unknown. In the current study, we showed that FGF19 is overexpressed in 
gastric cancer and is associated with depth of invasion, lymph node metastasis, and TNM stage. In addition, in 
vitro experiments demonstrated that FGF19 is able to enhance migration and invasion abilities of gastric cancer 
cells. Given its great potency in gastric cancer progression, FGF19 may be an effective target of treatment for 
advanced gastric cancer patients.},
DOI = {10.3727/096504016X14537290676919}
}